Non-specific surface interactions (NSB)

Non-specific surface interactions refer to the spontaneous and unintended adsorption of biological molecules or pharmaceutical compounds onto solid surfaces through non-covalent forces such as van der Waals, hydrophobic, and electrostatic interactions. Unlike specific ligand-receptor binding, these interactions lack selectivity and can occur on laboratory plasticware, medical implants, and biosensor surfaces (Source: NIH Assay Guidance Manual). In drug discovery and development, non-specific binding is a significant confounding factor that can lead to inaccurate assay results, loss of drug potency, and protein denaturation. In clinical applications, these interactions are the primary cause of biofouling on medical devices, which can trigger inflammatory responses, thrombosis, or infection (Source: Journal of the Royal Society Interface). This phenomenon is not a therapeutic target but rather a technical challenge that must be managed to ensure drug efficacy and device biocompatibility. Strategies to mitigate these effects include surface modification with hydrophilic polymers like polyethylene glycol (PEG) or the addition of surfactants to experimental buffers. Understanding these interactions is crucial for the design of diagnostic tools and the formulation of biologics. Consequently, researchers often employ blocking agents like bovine serum albumin (BSA) to saturate surfaces and prevent the non-specific attachment of the analyte of interest.

Other names

Non-specific bindingSurface adsorptionNon-specific adsorptionBiofoulingProtein foulingNon-specific protein adsorption

Not applicable as this is a physical phenomenon rather than a biological target.